<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(9)</volume><submitter>Chen M</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Epilepsy is a common central nervous system disorder with pathological mechanisms including inflammation, ion channel impairment, and neurotransmitter imbalance. Despite the rapid development of current anti-epileptic drugs, epilepsy is not well controlled, so there is still a need for research on the mechanisms and new drug targets for epilepsy. CXCL14 is a member of the CXC family of chemokines, and its receptor is currently unknown. Chemokines are the third major communication mediators in the central nervous system and play a role in many diseases. Therefore, we explore the expression of CXCL14 in epilepsy and its possible mechanisms.&lt;h4>Materials and methods&lt;/h4>We chose the kainic acid (KA) mouse model as the epilepsy model, and studied the expression of CXCL14 in t</pubmed_abstract><journal>American journal of translational research</journal><pagination>6222-6233</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9556486</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CXCL14 exacerbates seizures by inhibiting GABA metabolism in epileptic mice.</pubmed_title><pmcid>PMC9556486</pmcid><pubmed_authors>Ding X</pubmed_authors><pubmed_authors>Cao X</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>He W</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Tan J</pubmed_authors><pubmed_authors>Jiang G</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors></additional><is_claimable>false</is_claimable><name>CXCL14 exacerbates seizures by inhibiting GABA metabolism in epileptic mice.</name><description>&lt;h4>Objective&lt;/h4>Epilepsy is a common central nervous system disorder with pathological mechanisms including inflammation, ion channel impairment, and neurotransmitter imbalance. Despite the rapid development of current anti-epileptic drugs, epilepsy is not well controlled, so there is still a need for research on the mechanisms and new drug targets for epilepsy. CXCL14 is a member of the CXC family of chemokines, and its receptor is currently unknown. Chemokines are the third major communication mediators in the central nervous system and play a role in many diseases. Therefore, we explore the expression of CXCL14 in epilepsy and its possible mechanisms.&lt;h4>Materials and methods&lt;/h4>We chose the kainic acid (KA) mouse model as the epilepsy model, and studied the expression of CXCL14 in t</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-18T22:38:41.942Z</modification><creation>2025-04-07T10:26:10.499Z</creation></dates><accession>S-EPMC9556486</accession><cross_references><pubmed>36247285</pubmed></cross_references></HashMap>